recent, District Court in The Hague, the Netherlands for Edwards Life Sciences (Edwards Life Sciences) With Meiluo Life Science Company (Meril Life Sciences) The dispute between the two sides was decided, It ruled that Edwards' patent claims were invalid in the Netherlands and dismissed the company's infringement claims against Merlo. Over the years, The two companies have been locked in a battle over heart valve technology.

The dispute between Edwards and Merlo involved multiple jurisdictions and a number of patents, And these patents all relate to minimally invasive heart valve technology.

At present, Right after Edwards filed an infringement claim against his competitor, The District Court of The Hague in the Netherlands ruled in favor of Merlo. Due to the lack of novelty in the relevant patents, Therefore, the court rejected the above infringement claim, And ruled that Edwards Corporation No EP3494930 the, Relate to "Prosthetic valve lobe attachment frame" The European patent is invalid in the Netherlands. Edwards had previously sought an injunction. The patent relates to steps for installing a balloon catheter that includes an inflatable balloon, as well as an artificial aortic valve that can be expanded using the balloon.

Edwards said it would appeal the ruling.

Merlo was compensated

Edwards accused the Indian medical technology company Merlo of its products Myval TVH and Navigator Infringed on its products. The two products are the aortic valve prosthesis and the prosthesis delivery system. therewith, Meiluo filed an invalid counterclaim.

The court eventually ruled in Milo's favor, And pointed out that Edwards used EP3494930 Patent No. 2 took the wrong customs measures against its competitors. therefore, The court ordered Edwards to immediately stop any customs measures he had taken, And stop seizing any products. In addition, The court also ordered Edwards to compensate Merlo for the losses incurred as a result of the customs measures taken by the company.

Edwards Life Sciences offers a total of heart valves 4 Seed size, And can be customized according to the patient's physical condition. however, The size of the products offered by Meilo can be changed on a larger scale. During the trial, The Hague District Court ruled EP3494930 The number of patents compared to a patent called "Lobbi" The prior art lacks novelty.

evident, Courts in the Netherlands and the European Patent Office (EPO) Took a very different approach. 2022 years 5 month, EPO Dissenting department identified EP3494930 Patent No. 1 is novel and creative compared to prior art, Therefore, the patent is considered valid. At present, Meiluo Company is waiting for its direction EPO Results of the appeal filed by the Technical Appeals Board. Merlo had also petitioned the Hague District Court EPO Stay the proceedings pending a further ruling on the validity of the patent. merely, In light of the latest verdict, The request has become irrelevant.

Refer to EP3494930 The patent is still pending in Denmark, Greece, Hungary, Italy, Poland, Portugal, Slovakia, It continues in places like Spain and Turkey. In addition, For Meilo and its products Myval Other patent lawsuits are also underway in the Netherlands. Up to now, The parties have not yet filed a lawsuit against the patent with the Unified Patent Court. merely, Edwards already has the number EP2628464 and EP3646825 The patents are located in Stockholm in Northern Europe—The Baltic branch and the local branch in Munich were introduced to Merlo 2 Tort action.

At the same time, The American company is also known as EP3763331 An application for an interim measure against Merlo was filed with the local branch in Munich for the patent of the artificial valve crimping device. (Be compiled from www. juve-patent. com)

TRANSLATORS: Liu Peng　proofread: Rason group



　　disclaimer: This network reprint or compile the original articles are from the network, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact us, This website will be corrected in due course, delete, thank you.